Endnote
Payer L. Disease-mongers: How Doctors, Drug companies, and insurers are making you feel sick. New York, John Wiiey & Sons, 1992.
Moynihan R, Heath I and Henry D, ‘Selling sickness: the pharmaceutical industry and disease mongering’, British Medical Journal, vol. 324, 2002, pp. 886–891.
Public Library of Science Medicine vol. 3, no. 4, April 2006, available at www.medicine.plosjournals.org.
Moynihan R and Henry D, ‘The fight against disease mongering: Generating knowledge for action’, PLoS Medicine, vol. 3, no. 4, 2006, pp. 425–428: Greenhalgh T, ‘Narrative based medicine in an evidence based world’, British Medical Journal, vol. 318, 1999, pp. 323–25.
Mordacci R, ‘The desire for health and the promises of medicine’, Medicine, Health Care and Philosophy, vol. 1, no. 1, 1998, p. 21.
Smith R, ‘In search of non-disease’, British Medical Journal, vol. 324, 2002, p. 885.
Scully JL, ‘What is a disease? Disease, disability and their definitions’, European Molecular Biology Organization, vol. 5, no. 7, 2004, pp. 650–653.
Tiefer L, ‘Female sexual dysfunction: a case study of disease mongering and activist resistance’, PLoS Medicine, vol. 3, no. 4, 2006, pp. 436–440.
Woloshin S and Schwartz L, ‘Giving legs to restless legs: a case study of how the media helps make people sick’, PLoS Medicine, vol. 3, no. 4, 2006. pp. 452–455.
Jutel A, Does size really matter? weight and values in public health, perspectives in Biology and Medicine, vol. 44, no. 2, 2001, pp. 283–296.
Smith, ‘In search of non-disease’, op. cit., p. 885.
Parsons T, ‘Definitions of health and illness in the light of American values and social structure’, in Jaco, Patients, Physicians and Illness: behavioral science and medicine, Glencoe, IL: The Free Press, 1958, pp, 165–187.
Woloshin and Schwartz, ‘Giving legs to restless legs, op cit., p. 452.
Moynihan and Henry ‘The fight against disease mongering, op. cit.,pp. 425–428.
Chan B, ‘Exploiting marginality in health: Is ‘subhealth’ another case of disease mongering?’ First Inaugural Disease Mongering Conference, Newcastle, Australia, 2006.
This concept of a transformative zone of being was developed (mongered) by Professor Wang Yu Xue, of the Haier Pharmaceutical Company in China and is now the focus of some medical interest in many regions of China.
Moynihan and Henry, ‘The fight against disease mongering, op.cit., p. 427.
An interesting linguistic paradox which confronts me as I write this paper, and which is significant to the conceptualization of disease is the fact that stylistic convention would have me write that an individual ‘suffers’ from a disease or pathology, presuming a link between the two which I will argue is not inherent.
Bourke AP, Medicine and Compassion: what ought to be the place of compassion in the practice of medicine? Unpublished Masters thesis, Monash University, 1998.
Cassell EJ, The nature of suffering and the goals of medicine, New York: Oxford University Press, 1991, p. 32.
Nordenfelt L, On the nature of health, Dordecht: Kluwer, 1995.
Whitbeck C, ‘A theory of health in Caplan’: in Engelhardt and McCartney, Concepts of Health and Disease: Interdisciplinary perspectives, Reading, MA: Addison-Wesley Publishing Company, 1981, p. 620.
Cassell EJ, The nature of suffering, op.cit., p. 53.
Wazana A, ‘Physicians and the pharmaceutical industry. Is a gift ever just a gift?’ Journal of the American Medical Association, vol. 283, no. 3, 2000, pp. 373–380.
Madhavan S, Amonkar MM, Elliot D, Burke K and Gore P, ‘The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians’, Journal of Clinical Pharmacy and Therapeutics, vol. 22, no. 3, 2003, pp. 207–215; Herxheimer A, ‘Relationships between the pharmaceutical industry and patients organisations’, British Medical Journal, vol. 326, 2003, pp. 1208–1210.
Lexchin J, Bero LA, Djulbegovic B and Clark O, ‘Pharmaceutical industry sponsorship and research outcome and quality: systematic review’, British Medical Journal, vol. 326, 2003, pp. 1167–1170.
Melander H, Ahlqvist-Rastad J, Meijer G and Beermann B, ‘Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications’, British Medical Journal, vol. 326, 2003, pp. 1171–1173.
Menkes D, ‘Psychiatrist subscribing preferences and attitudes toward promotion’, First Inaugural Disease Mongering Conference, Newcastle, Australia, 2006..
Madhavan, Amonkar, Elliot, Burke and Gore, ‘The gift relationship’, opt.cit.,pp. 207–215; Herxheimer A, ‘Relationships between the pharmaceutical industry and patients organisations’, op.cit., pp. 1208–1210.
The adjective ‘patient’ is used consciously, with an awareness of the overlapping significance of its nominal and adjectival forms.
Pratt L, Seligmann A and Reader G, ‘Physicians’ views on the level of medical information among patients’, in Jaco, Patients, Physicans and Illness, op.cit.,:pp. 222–228.
Emanuel E, and Emanuel L ‘Four models of the physician-patient relationship’, Journal of the American Medical Association, vol. 267, no. 16, 1992, pp. 2221–2226.
Cassell E, The Nature of Suffering and the Goals of Medicine, USA: Oxford University Press, Reprint edition, 1994, p. 20.
Greenhalgh, ‘Narrative based medicine’, op.cit., p. 323.
Rosenberg CE, ‘The tyranny of diagnosis: specific entities and individual experience’, The Milbank Quarterly, vol. 80, no. 2, pp. 237–260.
National Institutes of Health, ‘Clinical Guidelines on the Identification, evaluation and treatment of overweight and obesity in adults’, Washington, U.S. Department of Health and Human Services.
Foucault M, Naissance de la clinique. Une archéologie du regard médical, Paris: Presses Universitaires de France, 1963, p. 8.
Rosenberg, ‘The tyranny of diagnosis’ op.cit., p. 257.
Emanuel E, and Emanuel L ‘Four models’ op.cit., pp. 2221–2226.
Buetow S, ‘To care is to coprovide’, Annals of Family Medicine, vol. 3, no.6, 2005, pp.553–555.
Lupton D, ‘Consumerism, reflexivity and the medical encounter’, Social Science and Medicine, vol. 45, no. 3, 1997, pp. 373–381.
Donchin A, ‘Understanding autonomy relationally: toward a reconfiguration of bioethical principles’, The Journal of Medicine and Philosophy, vol. 26, no. 4, p. 382.
Macdonald C, ‘Relational professional authority’, Cambridge Quarterly of Healthcare Ethics, vol. 11: pp. 282–89.
Dalmiya V, ‘Why should a knower care?’, Hypatia, vol. 17, no. 1, pp. 34–52.
ibid., p. 39
Readers might wish to refer to Carl Elliott’s Better than Well which explores how the quest for cultural conformity in the absence of illness results in an obsessive pursuit of enhancement and self-improvement via medical and pharmaceutical therapy, Elliot C, Better than well: American medicine meets the American dream, New York: W.W. Norton and Company, 2003.)
Rights and permissions
About this article
Cite this article
The representation of health, sub-health and disease (Chan, 2006). Monash Bioethics Review 25, 10–23 (2006). https://doi.org/10.1007/BF03549809
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03549809